JPS58134032A - 制癌性製剤 - Google Patents

制癌性製剤

Info

Publication number
JPS58134032A
JPS58134032A JP57015574A JP1557482A JPS58134032A JP S58134032 A JPS58134032 A JP S58134032A JP 57015574 A JP57015574 A JP 57015574A JP 1557482 A JP1557482 A JP 1557482A JP S58134032 A JPS58134032 A JP S58134032A
Authority
JP
Japan
Prior art keywords
anticancer
liposomes
cancer
liposome
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57015574A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0355450B2 (cg-RX-API-DMAC10.html
Inventor
Yoshiyuki Hashimoto
橋本 嘉幸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP57015574A priority Critical patent/JPS58134032A/ja
Publication of JPS58134032A publication Critical patent/JPS58134032A/ja
Publication of JPH0355450B2 publication Critical patent/JPH0355450B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP57015574A 1982-02-04 1982-02-04 制癌性製剤 Granted JPS58134032A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57015574A JPS58134032A (ja) 1982-02-04 1982-02-04 制癌性製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57015574A JPS58134032A (ja) 1982-02-04 1982-02-04 制癌性製剤

Publications (2)

Publication Number Publication Date
JPS58134032A true JPS58134032A (ja) 1983-08-10
JPH0355450B2 JPH0355450B2 (cg-RX-API-DMAC10.html) 1991-08-23

Family

ID=11892499

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57015574A Granted JPS58134032A (ja) 1982-02-04 1982-02-04 制癌性製剤

Country Status (1)

Country Link
JP (1) JPS58134032A (cg-RX-API-DMAC10.html)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63503113A (ja) * 1986-04-23 1988-11-17 ニューヨーク ユニバーシィティ 接触一抑制性因子の製造法
JPH01113319A (ja) * 1987-10-27 1989-05-02 Nippon Oil & Fats Co Ltd リポソームカプセル化したマクロファージ活性化剤
US6045774A (en) * 1997-01-10 2000-04-04 Epicyte Pharmaceutical Inc. J chain polypeptide targeting molecule linked to an imaging agent
US6251392B1 (en) 1997-10-20 2001-06-26 Epicyte Pharmaceuticals, Inc. Epithelial cell targeting agent
KR20030075213A (ko) * 2002-03-16 2003-09-26 (주)케비젠 항암물질을 함유하는 수용성 필름제 및 이의 제조방법
US7311912B1 (en) 1997-01-10 2007-12-25 Plantbodies Corporation Epithelial tissue targeting agent
WO2020241830A1 (ja) 2019-05-29 2020-12-03 学校法人早稲田大学 生体分子の検出のための温度応答性蛍光粒子

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63503113A (ja) * 1986-04-23 1988-11-17 ニューヨーク ユニバーシィティ 接触一抑制性因子の製造法
JPH01113319A (ja) * 1987-10-27 1989-05-02 Nippon Oil & Fats Co Ltd リポソームカプセル化したマクロファージ活性化剤
US6045774A (en) * 1997-01-10 2000-04-04 Epicyte Pharmaceutical Inc. J chain polypeptide targeting molecule linked to an imaging agent
US6391280B1 (en) 1997-01-10 2002-05-21 Epicyte Pharmaceutical, Inc. J chain polypeptide targeting molecule linked to an imaging agent
US7022309B2 (en) 1997-01-10 2006-04-04 Biolex Newco I, Inc. Targeting molecule linked to an imaging agent
US7311912B1 (en) 1997-01-10 2007-12-25 Plantbodies Corporation Epithelial tissue targeting agent
US6251392B1 (en) 1997-10-20 2001-06-26 Epicyte Pharmaceuticals, Inc. Epithelial cell targeting agent
US6440419B1 (en) 1997-10-20 2002-08-27 Epicyte Pharmaceutical, Inc. Epithelial cell targeting agent
KR20030075213A (ko) * 2002-03-16 2003-09-26 (주)케비젠 항암물질을 함유하는 수용성 필름제 및 이의 제조방법
WO2020241830A1 (ja) 2019-05-29 2020-12-03 学校法人早稲田大学 生体分子の検出のための温度応答性蛍光粒子

Also Published As

Publication number Publication date
JPH0355450B2 (cg-RX-API-DMAC10.html) 1991-08-23

Similar Documents

Publication Publication Date Title
US5837845A (en) Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
HU190908B (en) Process for preparing humane-humane hybridomes and - by means thereof - monoclonal antibodies
Tsutsumi et al. Immunohistochemical observations of carcinoembryonic antigen (CEA) and CEA-related substances in normal and neoplastic pancreas: Pitfalls and caveats in CEA immunohistochemistry
JPH11505108A (ja) 結合能力が光開裂性分子により可逆的に阻害される二重特異性抗体
JPH04346918A (ja) 薬剤含有タンパク質結合リポソーム
JPS61227532A (ja) 抗体ハイブリツド分子およびその製造方法
PT89385A (pt) Processo para a preparacao de novos anticorpos
JPS58208238A (ja) 共有結合によつて酵素と抗体を結合させる新しい共役物とこの共役物を用いた医薬会合
EP0614486A1 (en) Targeted delivery of virus vector to mammalian cells
JPS61500789A (ja) モノクロ−ナル抗−ヒト乳癌抗体
JPH0759518B2 (ja) 自己由来のワクチン
JP2022087135A (ja) 複数細胞標的化リポソーム
JPS58135821A (ja) リチンの鎖状部aと特異モノクロノ−ル抗体により構成される白血病t治療用抗癌剤
US6136313A (en) Processes and intermediates for synthetic antibody derivatives
CA2387383C (fr) Utilisation d'anticorps monoclonaux anti-ferritines dans le traitement de certains cancers
JPH0355450B2 (cg-RX-API-DMAC10.html)
Gregoriadis et al. Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo. Some influencing factors
JP3223159B2 (ja) モノクローナル抗体の製造方法
Samaan et al. Ectopic parathyroid hormone production by a squamous carcinoma of the tonsil
JPH022394A (ja) アンスラサイクリン化合物に対するモノクロナール抗体
FR2543971A1 (fr) Anticorps contre le cancer humain de la vessie
JPH0276899A (ja) 双特異性抗体の製造法
JPH0433935A (ja) ロドプシン薄膜とその作製方法
CA1329545C (en) Immunological complex, its preparation and its use
Haimovich et al. Cell surface components of carcinogen‐induced lymphoid tumors in SJL/J mice